DE69934410D1 - Behandlung von akne und photobedingter alterung durch topische kurzzeitbehandlung mit retinoiden - Google Patents

Behandlung von akne und photobedingter alterung durch topische kurzzeitbehandlung mit retinoiden

Info

Publication number
DE69934410D1
DE69934410D1 DE69934410T DE69934410T DE69934410D1 DE 69934410 D1 DE69934410 D1 DE 69934410D1 DE 69934410 T DE69934410 T DE 69934410T DE 69934410 T DE69934410 T DE 69934410T DE 69934410 D1 DE69934410 D1 DE 69934410D1
Authority
DE
Germany
Prior art keywords
treatment
short
acne
photobed
retinoids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69934410T
Other languages
English (en)
Other versions
DE69934410T2 (de
Inventor
Susan Bershad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/123,589 external-priority patent/US6017938A/en
Application filed by Individual filed Critical Individual
Publication of DE69934410D1 publication Critical patent/DE69934410D1/de
Application granted granted Critical
Publication of DE69934410T2 publication Critical patent/DE69934410T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DE69934410T 1998-07-28 1999-07-28 Behandlung von akne und lichtbedingter alterung durch kurzzeitbehandlung mit topischen retinoiden Expired - Fee Related DE69934410T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US249371 1994-05-24
US09/123,589 US6017938A (en) 1998-07-28 1998-07-28 Short contact treatment for acne
US123589 1998-07-28
US09/249,371 US6083963A (en) 1998-07-28 1999-02-12 Short contact treatment of photoaging with topical retinoids
PCT/US1999/017020 WO2000006118A2 (en) 1998-07-28 1999-07-28 Short contact treatment of acne and photoaging with topical retinoids

Publications (2)

Publication Number Publication Date
DE69934410D1 true DE69934410D1 (de) 2007-01-25
DE69934410T2 DE69934410T2 (de) 2007-09-27

Family

ID=26821705

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69934410T Expired - Fee Related DE69934410T2 (de) 1998-07-28 1999-07-28 Behandlung von akne und lichtbedingter alterung durch kurzzeitbehandlung mit topischen retinoiden

Country Status (9)

Country Link
US (1) US6096765A (de)
EP (1) EP1100490B1 (de)
AT (1) ATE347885T1 (de)
AU (1) AU5132799A (de)
CY (1) CY1106036T1 (de)
DE (1) DE69934410T2 (de)
DK (1) DK1100490T3 (de)
ES (1) ES2279624T3 (de)
WO (1) WO2000006118A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040204492A1 (en) * 2003-04-03 2004-10-14 Healthpoint, Ltd. Topical composition and method for treating seborrheic dermatitis
CA2457214A1 (en) * 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
US20060020037A1 (en) * 2004-07-22 2006-01-26 Allergan, Inc. Tazarotenic acid and esters thereof for treating autism
FR2879459B1 (fr) * 2004-12-22 2007-02-16 Galderma Res & Dev Composition comprenant de l'adapalene solubilise avec des cyclodextrines
AR054805A1 (es) * 2005-06-29 2007-07-18 Stiefel Laboratories Composiciones topicas para el tratamiento de la piel
EP1919606A2 (de) 2005-08-02 2008-05-14 Sol-Gel Technologies Ltd. Metalloxidbeschichtung von wasserunlöslichen bestandteilen
US9107844B2 (en) * 2006-02-03 2015-08-18 Stiefel Laboratories Inc. Topical skin treating compositions
BRPI0709674A2 (pt) 2006-03-31 2011-12-06 Stiefel Res Australia Pty Ltd gel de suspensão espumante
EP2109445B1 (de) 2007-02-01 2022-04-20 Sol-Gel Technologies Ltd. Zusammensetzungen zur topischen anwendung mit einem peroxid und einem retinoid
ES2763829T3 (es) * 2007-02-01 2020-06-01 Sol Gel Tech Ltd Método para preparar partículas que comprenden un revestimiento de óxido de metal
US20090137534A1 (en) * 2007-11-26 2009-05-28 Chaudhuri Ratan K Skin treatment compositions and methods
FR2925313A1 (fr) * 2007-12-19 2009-06-26 Oreal Utilisation cosmetique de proteines de type plakoglobine
MX2012000768A (es) * 2009-07-16 2012-02-13 Stiefel Laboratories Derivados de tazaroteno.
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
WO2017011600A1 (en) 2015-07-13 2017-01-19 Dr. Reddy's Laboratories, Ltd. Topical retinoid compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4247547A (en) * 1979-03-19 1981-01-27 Johnson & Johnson Tretinoin in a gel vehicle for acne treatment
US5516793A (en) * 1993-04-26 1996-05-14 Avon Products, Inc. Use of ascorbic acid to reduce irritation of topically applied active ingredients
US5650279A (en) * 1995-01-27 1997-07-22 Allergan, Inc. Gene sequence induced in skin by retinoids
US5719195A (en) * 1995-05-05 1998-02-17 4 Thought Technologies Treatment of psoriasis with 11-cis-retinoic acid
US5776687A (en) * 1997-02-28 1998-07-07 Allergan Retinoid induced gene

Also Published As

Publication number Publication date
EP1100490B1 (de) 2006-12-13
EP1100490A2 (de) 2001-05-23
ATE347885T1 (de) 2007-01-15
WO2000006118A3 (en) 2000-05-04
CY1106036T1 (el) 2011-04-06
US6096765A (en) 2000-08-01
ES2279624T3 (es) 2007-08-16
DE69934410T2 (de) 2007-09-27
DK1100490T3 (da) 2007-04-10
AU5132799A (en) 2000-02-21
WO2000006118A2 (en) 2000-02-10

Similar Documents

Publication Publication Date Title
DE69934410D1 (de) Behandlung von akne und photobedingter alterung durch topische kurzzeitbehandlung mit retinoiden
DE69636342D1 (de) Liponsäure in topischen mittel
ATE212827T1 (de) Abschuppende zusammensetzung von salicylsäure und zwitterionischen verbindungen
ATE191444T1 (de) Neue retinoidkonjugate zur behandlung von alterserscheinungen der haut
NO970580L (no) Retinsyre-X-reseptorligander
DE69905938D1 (de) Kombination von duloxetin mit nichtsteroid-entzündungshemmern für die behandlung von schmerz
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
DE69731477D1 (de) Mittel zur akne behandlung
DE69227306D1 (de) Behandlung von zellgewebsentzündung mit retinoide
CA2015838A1 (en) Method of topically treating acne vulgaris
ATE197889T1 (de) Kontrolle des haarwuchses
DE60218227D1 (de) Topisches dapson zur behandlung von akne
ATE174216T1 (de) Verwendung von l-carnitin-o-estern mit aromatischen säuren zur behandlung der dermatosen
FR2815859B1 (fr) Utilisation de l'association d'au moins un carotenoide a activite provitaminique a et d'au moins un carotenoide sans activite provitaminique a pour traiter les signes du vieillissement
DE69625182D1 (de) Immunoglobuline der g-klasse zur lokalen behandlung von hautentzündungen
DE69129693D1 (de) Verwendung von nickel und bromide ionen für die behandlung von psoriasis
EA199800194A1 (ru) Способ косметического лечения и предупреждения появления признаков старения кожи
ES2134430T3 (es) Procedimiento de fluoracion.
ATE102824T1 (de) Verwendung von retinoiden zur verhinderung und verkleinerung von dehnungsstreifen.
DE69432749D1 (de) Topische und systemische anwendung von buspiron und seinen derivaten zur behandlung von pathologischen zuständen, die mit immunantworten verbunden sind
WO2002041832A3 (en) Compositions having comfrey and methods for reducing retinoid-induced skin irritation
ES9600001A1 (es) Procedimiento y composicion para el ondulado permanente del cabello
SE9904059D0 (sv) Serine protease and topical retinoid compositions
ATE240110T1 (de) Verwendung von natriumchlorid zur behandlung der akne und/oder der rosacea
DE68912227D1 (de) Behandlung von Periodontoklasie mit Retinsäure.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee